BCL2 and cancer: Studies have reported that Bcl2 is an anti‐apoptotic protein in cancers, whereas Bax has a pro‐apoptotic effect, and the radio of Bax to Bcl‐2 is used to determine whether the cells will commit to apoptosis (Green and Reed, 1998; Gao and Dou, 2000).